Adalimumab

Details

Files
Generic Name:
Adalimumab
Project Status:
Withdrawn
Therapeutic Area:
ulcerative colitis
Manufacturer:
AbbVie
Call for patient/clinician input open:
Brand Name:
Humira
Project Line:
Reimbursement Review
Project Number:
SR0365-000
Call for patient/clinician input closed:
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Ulcerative colitis